Actonel for osteoporosis cleared for use once per month
A new dosage form of once per month is now available for the osteoporosis drug Actonel.
Actonel (risedronate sodium), which is now available in daily, weekly, and two-tablets-per-month dosage forms, has now been approved for once a month (150 mg) administration. Co-promoted by Procter & Gamble and sanofi-aventis, the bisphosphonate is designed to reduce the risk of fractures in postmenopausal women with osteoporosis.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.